Formycin is an investigational drug.
There have been 12 clinical trials for Formycin.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2005.
The most common disease conditions in clinical trials are Leukemia, Lymphoma, and Leukemia, Lymphoid. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Eastern Cooperative Oncology Group.